Literature DB >> 1124797

Intravascular fibrin deposits, hepatic infarcts and thrombocytopenia in parent/F mouse chimeras with host-versus-graft syndrome.

R C Hard, W J Still.   

Abstract

Host-versus-graft (HVG) disease is the fatal result of the allogenic reaction which occurs in parental strain mice perinatally inoculated with F(1) hybrid spleen cells. The principal manifestations of the syndrome in RFM/(T(6) X RFM)F(1) mice are thrombocytopenia, intestinal hemorrhage, hepatic necrosis, lymphoproliferative disorders and renal disease due to immune complexes. The discovery of intravascular fibrin deposits in the present studies establishes disseminated intravascular coagulation (DIC) as an intermediary mechanism of HVG disease. It is suggested that the characteristic declines in blood platelet levels, intestinal hemorrhages and hepatic infarcts are triggered principally by immune complexes. Cellular infiltrates of the liver, granulocytosis and hypergammaglobulinemia are other abnormalities which are regularly found in HVG mice and which are also thought to predispose to DIC.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124797      PMCID: PMC1912648     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  DISEASES OF HYPERSENSITIVITY.

Authors:  D G MCKAY
Journal:  Arch Intern Med       Date:  1965-07

3.  AN H-2 ANALYSIS OF STRAIN RFM/UN MICE.

Authors:  D M POPP; D B AMOS
Journal:  Transplantation       Date:  1965-07       Impact factor: 4.939

4.  Demonstration of F1 hybrid anti-parent immunological reaction.

Authors:  F CELADA; W J WELSHONS
Journal:  Proc Natl Acad Sci U S A       Date:  1962-03-15       Impact factor: 11.205

5.  Electron microscopic appearance of fibrin in thin sections.

Authors:  W J STILL; E H BOULT
Journal:  Nature       Date:  1957-04-27       Impact factor: 49.962

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Similarity of cellular recognition structures for histocompatibility antigens and of combining sites of corresponding alloantibodies.

Authors:  H Ramseier; J Lindenmann
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

8.  Plasma protein requirements for human platelet aggregation.

Authors:  N U Bang; R O Heidenreich; C W Trygstad
Journal:  Ann N Y Acad Sci       Date:  1972-10-27       Impact factor: 5.691

9.  THE APPEARANCE OF A HEPATOTROPHIC VIRUS IN MICE THYMECTOMIZED AT BIRTH.

Authors:  J EAST; D M PARROTT; F C CHESTERMAN; A POMERANCE
Journal:  J Exp Med       Date:  1963-12-01       Impact factor: 14.307

10.  Studies on the generalized Shwartzman reaction: I. General observations concerning the phenomenon.

Authors:  L THOMAS; R A GOOD
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

View more
  7 in total

Review 1.  Pathology, immunology and virology of the host versus graft syndrome.

Authors:  R C Hard; S S Cross
Journal:  Surv Immunol Res       Date:  1983

2.  Sequential changes in serum immunoglobulin levels in young RFM mice with host-versus-graft disease.

Authors:  R C Hard
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

3.  Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.

Authors:  R C Hard
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

4.  Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.

Authors:  M Tateno; N Kondo; T Itoh; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

5.  Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.

Authors:  S S Cross; G Brede; H S Tucker; M Maloney; J L Montour; R C Hard
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.

Authors:  R C Hard; M R Patel; L M Keller; T J Linna
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

7.  Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.

Authors:  R C Hard; J L Montour; B A Fuchs
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.